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ABSTRACT 
Corneal disease is a significant cause of decreased vision or blindness 
in the horse worldwide. Numerous topical and systemic drugs over a 
prolonged period of time may be used to treat an equine corneal ulcer. 
Despite the high prevalence of corneal disease and ulceration in the horse, 
and the complexity of corneal wound healing, research is limited and more 
heavily devoted to in vivo studies whose limitations include small sample 
sizes and ethical considerations. Bench top laboratory in vitro studies are 
limited in number and overlook the complexity of corneal wound healing by 
assessing each corneal layer separately from its neighbor.  
The objective of this study was to develop a novel ex vivo model of 
equine corneal wound healing that maintained structural integrity, and is 
physiologically relevant, mimicking in vivo events.   
 In this randomized and controlled study, fourteen equine corneas were 
harvested within two hours of humane euthanasia for reasons unrelated to 
this study. All donors were screened and corneas were included if they were 
free of ocular and systemic disease. Corneas were immediately processed 
and corneoscleral rims excised 2 mm posterior to the limbus.  Corneas were 
randomly assigned to one of the following groups: wounded (n=8) or 
unwounded (n=6) controls. Each pair of eyes was divided such that corneas 
from the same horse were assigned to a different group. In the event that only 
one of the two eyes was included, the eye was assigned to the wounded 
group. In the ‘wounded’ group, the axial cornea was wounded for 60 seconds 
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with a 6 mm disk of filter paper soaked in 1N sodium hydroxide (NaOH). 
Epithelial ulceration was confirmed employing fluorescein stain. 
Subsequently, all corneas were cultured using an air-liquid interface model in 
complete media. The corneal cups were placed on a rocker set at a 6 degree 
incline and incubated at 37 °C with 5% CO2 humidity. The media bathed the 
cornea 8 times per minute to simulate normal horse blinking. Evaluation of 
corneal healing was performed daily and included fluorescein staining and 
fluorescein retention (i.e. ulcer measurements). Corneas from both groups 
were randomly assigned to undergo further processing via histopathology at 
designated time points of 24 hours (T24; n=5), T48 (n=5), and T72 (n=4) post 
wounding, and stained with hematoxylin and eosin. Structural integrity and 
pathologic changes to the corneal epithelium, stroma, Descemet’s membrane 
and endothelium were assessed. Interleukin-6 (IL-6) expression was then 
evaluated by means of RNAscope in situ hybridization.  
All wounded corneas healed within 72 hours. Histologically, normal 
corneal architecture was observed including intact epithelium, minimal stromal 
edema, and presence of endothelium. Increased IL-6 expression was noted in 
wounded corneas compared to unwounded controls and was predominantly 
in the metabolically active basal epithelial cell layer. As the corneal wound 
healing progressed, IL-6 expression decreased. 
The equine air-liquid interface, ex vivo, corneal wound healing model is an 
effective and physiologically relevant model. This model can be utilized to reduce or 
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eliminate the use of live horses for corneal wound healing studies, while providing an 
effective platform for corneal wound healing research in this species. 
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CHAPTER 1. GENERAL INTRODUCTION 
 
Structure of the Equine Cornea 
The cornea and sclera are part of the fibrous tunic of the eye and their 
junction is known as the limbus. The cornea makes up approximately 20% of this 
outer fibrous tunic and due to its transparency, curvature, and air liquid interface with 
the outer precorneal tear film (PTF) and the inner ocular media, is the most 
refractive part of the eye.1,2,3 Because of its anterior location, its purpose is also to 
protect the inner contents of the eye.4 This elliptically shaped structure is comprised 
of four main layers in the horse, including the epithelium, stroma, Descemet’s 
membrane, and the endothelium (Fig. 1-1). 1,2 In the horse, the average total 
thickness of the cornea is between 700 and 900 µm.5,6,7 
 
Epithelium  
The corneal epithelium is the anterior most layer of the cornea and is a 
continuation of the conjunctival epithelium (Fig. 1-1). It is in contact with the PTF 
superficially, which also aids in light refraction. The main function of the epithelium is 
to serve as a barrier against infection, thereby protecting the rest of the eye.2 As the 
cornea is maintained in a state of relative dehydration, any loss of this hydrophobic 
layer (i.e. ulceration) may compromise the cornea’s transparency via an influx of 
water from tears.1 Clinically this is appreciated as corneal edema and experimental 
removal of this layer results in a 200% increase in corneal thickness within 24 
hours.8 In the horse, this layer is up to 15 cell layers thick and consists of three cell 
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types, which from anterior to posterior are known as superficial epithelial cells, wing 
cells, and basal cells.9,10,11 These different cell types communicate with themselves 
and one another using different intercellular junctions including desmosomes, gap 
junctions, and zonula occludens.1,12 These modes of communication contribute to 
expedient wound healing.13 As the superficial epithelium is constantly being 
sloughed off, or desquamating, the deeper wing cells proliferate and move towards 
the corneal surface, while the basal cells then differentiate into wing cells. 
Additionally, corneal stem cells are housed in the limbus, or corneaoscleral junction, 
and as the three cell types push anteriorly, the stem cells migrate centripetally to ‘re-
stock’ the basal and superficial layers.14,15 
 
Stroma 
The stroma is deep to the epithelium, comprises about 90% of the total 
corneal thickness and is 78% water (Fig. 1-1).1 This layer is made up of collagen 
fiber bundles known as lamellae which run parallel to, and across the length of the 
cornea. The stroma is further subdivided into the anterior stroma and posterior 
stroma. The anterior portion is considered to be less orderly and the lamellae are 
smaller in both thickness and width compared to the posterior stroma.1 They are 
arranged in a more oblique, or woven, orientation. Deep to the anterior stroma is the 
posterior stroma, whose broad sheets of lamellae are lined up in a more parallel, 
uniform, nonwoven orientation. In general, the stroma’s collagen fibrils are more 
precisely arranged with fewer spaces between the fibrils in the central zone versus 
the peripheral. This specific organization of the corneal stroma also plays a large 
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role in maintaining corneal clarity.16,17 Distributed in between the lamellae is the 
predominant stromal cell type, known as the keratocyte, which communicate via tight 
and gap junctions. Other cells that may reside normally within the stroma include 
macrophages, dendritic cells and lymphocytes.1,18 
 
Descemet’s membrane 
The next corneal layer is Descemet’s membrane, which is the basement 
membrane of the endothelium (Fig. 1-1). It is also composed of collagen similar to 
the stroma; however, this collagen is more layered, which gives it an elastic property 
that is more resistant to trauma. Descemet’s membrane is approximately 10 µm 
thick and it thickens with age. This thin layer is thought to have regenerative 
properties.15 
 
Endothelium 
The inner most layer of the cornea is the endothelium (Fig. 1-1). In this 
delicate, 5 µm monolayer, cells are joined to one another via tight and gap junctions. 
This layer’s function includes actively pumping aqueous humor via Na+/K+-ATPase 
pumps back into the anterior chamber, and it is most responsible for maintaining a 
state of relative dehydration in the cornea.1,8 This has been demonstrated 
experimentally, in which removal of the endothelium resulted in an increase of 
greater than 500% in overall corneal thickness.8 Most mammals are born with their 
total, maximum amount of endothelial cells, which slowly decreases with time. In the 
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horse, this endothelial cell density has been established at 3155+/-765 cells/mm2.7 
As this layer cannot generally undergo mitosis, it ‘heals’ itself by cellular spreading, 
causing changes in cell shape (pleomorphism) and size (polymegethism). Should 
the endothelial cellular density decrease by too large an index to pump fluid 
efficiently, severe, diffuse corneal stromal edema will result.15 In the dog, this has 
been established at less than 500 to 800 cells/mm2 and is known as corneal 
decompensation.1 To date, this threshold has not been determined in the horse.  
While the endothelium has the most active job in maintaining corneal 
transparency, compromise of any of the aforementioned layers will result in corneal 
pathology and an impaired visual axis.  Corneal clarity relies upon many factors 
including the presence of each layer, appropriate architectural integrity, and the 
individual cell’s ability to communicate with itself and its neighbors. These factors are 
the cornerstone of corneal wound healing. 
 
Corneal Wound Healing 
Corneal injuries are vision and eye threatening across species. Corneal 
healing is a complex process that involves all cellular layers and their ability to 
communicate via mediators with one another. Each layer responds differently to 
insult.  
 
Epithelial healing 
The corneal epithelium has stem cells located within the limbus of the eye. 
These corneal limbal stem cells are able to provide the cornea with a lifetime of 
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epithelium.19,20-25 The objective of epithelial wound healing is two-fold: first, to trigger 
migration of the epithelial cells to the wounded area, and second to upregulate cell 
proliferation and differentiation, all with the end goal of filling the defect and therefore 
healing the wound. This is done via autocrine and paracrine cellular mediated 
signaling with a significant amount of ‘cross talk’ between the corneal epithelium, 
limbal stem cells, and the underlying stromal cells.13 Initial factors that are released 
following epithelial wound healing include interleukin-1 (IL-1) and tumor necrosis 
factor alpha (TNF-α)13 and growth factors,26 that trigger the epithelial cells migration 
and then proliferation. Interleukin-6 (IL-6) also plays a large role, and has been 
shown to significantly increase epithelial wound healing rates in a rabbit in vivo 
model and to stimulate epithelial cell migration in rabbit in vitro models.27,28 
Additionally, matrix metalloproteinases are released, which cause the cells to 
disengage from one another and to release their cell matrix adhesions.29 
 
Stromal healing 
Due to this layer’s thickness, it goes without saying that the organized healing 
of the stroma is of paramount importance.15 Should this layer heal without the 
precision it requires, there will be a reduction in corneal transparency (i.e. fibrosis, or 
scar, formation), irregular light refraction, and therefore impaired vision. Damage to 
the stroma causes a large release of cytokines, that trigger apoptosis of underlying 
keratocytes.18,30-34 Once cleared of potentially damaged keratocytes, the remaining 
activated keratocytes transform into migratory fibroblasts and myofibroblasts. 
Fibroblasts secrete actin, a contractile cytoplasmic element, while myofibroblasts 
express a contractile cytoskeleton element known as alpha-smooth muscle actin (α-
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SMA). It is well known that the myofibroblast is only detected following stromal 
corneal wounding and its expression of α-SMA is credited with wound 
contracture.25,35 However, this spindeloid myofibroblast cell and its activity with the 
extracellular matrix (ECM), is at the heart of fibrosis formation within the cornea as 
the myofibroblast deposits new extracellular matrix and aberrant proteins to fill up 
the defect.36,37 With time, these proteins can form scar tissue,38-46 and as the ECM 
undergoes very slow turnover (years in humans) scar formation may persist.40-43,47,48 
As such, the “well meaning” myofibroblast has been linked to corneal haze and scar 
formation following wounding.18 Inflammatory cells including monocytes, 
macrophages, polymorphonuclear leukocytes, natural killer cells, and T cells also 
have a role in stromal wound healing. It is thought these cells enter the cornea at the 
limbus or through the circulatory system and tear film.18 The remodeling of the 
stroma is both complex and lengthy as the anterior and posterior stroma will take 
months to regain their normal, unique collagen fibril orientation.1 
 
Descemet’s membrane and endothelial healing 
Descemet’s membrane has regenerative properties, but similar to the 
endothelium, has not been studied extensively due to its more interior location 
relative to the outer stromal and epithelial layers.  Compared to epithelial and 
stromal wound healing, relatively less is known about endothelial wound healing, 
again due to this layer’s inner location within the cornea.  However, unlike the 
epithelium, the endothelium undergoes little to no proliferation, instead closing 
wound gaps by migration and spreading.49-52 In the rabbit, a transient morphology to 
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a myofibroblast-type, α-SMA expressing migratory cell has been noted.25,53,54 To 
date, this has not been demonstrated in the horse. 
 
Cellular communication 
There is a significant amount of ‘cross talk’ between the corneal layers, and 
while each layer heals uniquely, the overall tissue architectural organization lends 
itself to cellular communication.55 These corneal cells release mediators secondary 
to injury that are distributed throughout the cornea using gap junctions, tight 
junctions, and zonula occludens.1,13,18 Therefore, models of corneal wound healing 
that include all corneal layers and that maintain normal corneal architecture are of 
utmost importance.56 While in vitro assessment of cell lines is certainly important and 
not to be overlooked due to its relatively low cost and high speed, this type of over 
simplified model is not able to mimic the complexities of the interactions both at the 
corneal cellular level, nor at the corneal organ level.55 Further exploration of the 
interlayer communication in corneal wound healing may further advance our 
understanding of this complex process.  
 
Interleukin-6 Cytokine Activity 
Interleukin-6 is a potent immunologic mediator and it is involved in acute 
phases of inflammation.57 It is considered a myokine, or a cytokine produced from 
muscle, and when released by myocytes, serves a protective, anti-inflammatory role 
within the musculature.58,59 However, it is also a proinflammatory cytokine57 and its 
secretion from T cells and macrophages leads to inflammation and tissue damage 
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especially following burn trauma.58-60 Interleukin-6 has been extensively studied 
within the context of corneal wound healing and its expression is upregulated 
following corneal injury in humans, as well as in animal and in vitro models.60-64 
While the indirect suppression of IL-6 has been shown to have a negative effect on 
in vivo corneal epithelial cell migration in mice63 and on in vitro immortalized human 
corneal epithelial cell migration,61,63 increases in IL-6 expression actually expedite 
corneal wound closure in scratch assays employing human62,65 and rabbit corneal 
epithelial cells,66 and in in vivo rabbit corneal wound healing models.67 Interleukin-6 
has also been shown to increase in equine disease processes such as dermatologic 
epidermal wound healing,68 pneumonia,69 and endometritis.70 It is likely that IL-6 is 
one of the more systemically important equine cytokines. Although IL-6 expression 
has been demonstrated in rabbits,66,67 mice,60,62 and humans61,64,71 post corneal 
wounding, its role in equine corneal wound healing has not been studied to date.  
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Figure for Chapter 1 
 
 
 
 
Figure 1-1. Histologic section of a normal equine cornea. Note the superficial 
epithelial layer, consisting of approximately 15 epithelial cell layers, the well-
organized, thick, stromal layer, Descemet’s membrane, and the single-cell, inner-
most, endothelial layer (black arrow).  
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CHAPTER 2. LITERATURE REVIEW 
 
In vivo Corneal Wound Healing Studies 
 Ocular disease is one of the most common ailments of the horse1 and it is 
one of the most significant causes of decreased vision or blindness in the horse 
world-wide.2 This is likely due to several factors including a prominent globe, the 
lateral location of the globe within the skull, and the equid’s exuberant and head 
throwing behavior.1 As such, the horse is predisposed to corneal injury. Although 
equine corneal disease and the subsequent wound healing cascade is a complex 
process whose mechanisms are still not fully understood,3 it is known that 
inflammatory cells and their secretory products such as cytokines and growth factors 
are involved, as discussed in Chapter 1.  In addition, underlying genetics may also 
play a role3 and it has been suggested that the aggressiveness of the corneal 
destruction may be linked to the equine host’s immunophenotype.4 This includes the 
local innate response of Pattern and Damage Recognition Receptors (PRRs, DRRs) 
that reside within the corneal epithelium and their role in cytokine recruitment.4 
Hypothesis driven, in vivo, corneal wound healing studies have been conducted 
extensively in mice, rats, and rabbits,5-10 and included evaluation of corneal 
regeneration and healing processes, corneal epithelial cell migration, and IL-6 
expression.11 Additionally, the role of IL-6 in rabbit,12,13 mouse,5,14,15 and human16 
corneal wound healing has also been studied in vivo.  
 Despite the high prevalence of corneal disease and ulceration in the horse, 
the importance of a clear visual axis in this species, and the complexity of corneal 
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wound healing, few in vivo studies are hypothesis driven. Instead, most studies are 
heavily devoted to retrospective studies, reviewing patients’ medical records.17-24 
Only few hypothesis driven corneal wound healing studies have been conducted in 
vivo to date.25,26 The limitations of such studies include small sample sizes, high 
cost, ethical concerns, and large variation amongst few subjects which often results 
in a lack of statistical significance.27 An ex vivo equine corneal wound healing model 
can overcome these limitations, and provide the platform for hypothesis driven 
studies of corneal wound healing in the horse.  
 
 
In vitro Corneal Wound Healing Studies 
 In the laboratory setting, in vitro work possesses its own set of limitations. Cell 
culture lines that are purchased from commercial sources may be contaminated with 
other cell lines, may not be validated for the cellular phenotype in question, and may 
be over-passaged.28-31 Growing primary corneal cell cultures can prove to be a 
challenge as well. For example, while Mathes et al successfully established a 
reproducible cell culture model of equine keratocyte and endothelial cells, the 
epithelial cells grew slowly, did not survive multiple passages and were seen to 
suffer from keratocyte or fungal organism contamination.27 Additionally, by 
experimenting on individual corneal layers separately from neighboring layers,32,33 in 
vitro corneal research may be an overly simplified model which lacks the dynamic, 
physiological events of the in vivo corneal model.32-34 In vitro cell culture lines are not 
able to simulate the cornea’s complex molecular processes nor the interactions and 
‘cross talk’ amongst the corneal layers, especially the epithelium and stroma. For 
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example, it is well known that epithelial and stromal interactions are mediated by 
paracrine expression and that autocrine signaling is likely occurring as well.35,36 By 
studying and experimenting on one corneal layer at a time, it is likely the cell to cell 
and cell to extracellular matrix interactions (the ‘cellular microenvironment’) are 
overlooked.34,37-41 These intercellular interactions are paramount to the normal 
routine of the cell, and tissue injury can result in disruption of these connections and 
therefore cellular communication. Therefore, the cells’ ability to respond to its local 
environment is impeded, and cell migration, differentiation and healing are 
diminished37-41 as the individual cell is not able to communicate the signaling 
information on to groups of other cells.42-44 As such, the in vitro researcher may be 
faced with the challenge of obtaining clinically applicable results. 
  
 
Current Ex vivo Studies 
The inherent challenge comes in the desire to learn more about corneal 
wound healing without either harming healthy animals in vivo or struggling with 
clinical applicability in vitro. The ex vivo model of corneal wounding has been 
developed in other species including the human,45 dog,46 pig (authors unpublished 
data), and rabbit,47,48 and represents a logical stepping stone between the equine in 
vitro ocular bench top models and the in vivo clinical studies, all while providing 
physiologically-based, clinically applicable conclusions.48 Recent publications have 
revolutionized the ex vivo approach, demonstrating superior epithelial preservation 
using an air-liquid interface human ex vivo model.45 Deshpande et al refined the ex 
vivo corneal wound healing model, by ensuring that media rolled over the cultured 
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rabbit corneas. The technique resulted in an extended corneal lifespan of up to 4 
weeks, versus 2 weeks in static conditions.47 This modified technique allowed them 
to evaluate the inflammatory role of the cytokine interleukin-17A on their rabbit 
corneas over an extended period of time. Previously, Lin et al had evaluated the 
shorter term effects of interleukin-33 in a modified human ex vivo model.49 However, 
to our knowledge, IL-6 expression has not been studied utilizing the ex vivo corneal 
wound healing model. 
A species specific, reproducible model of corneal wound healing is of great 
importance. To date, no ex vivo models of equine corneal wound healing have been 
established. Therefore, the purpose of this study was two-fold. First, to establish an 
ex vivo model of equine corneal wound healing, and second, to investigate the 
physiologic relevance of this model. This study is at the heart of improved animal 
welfare and represents a logical stepping stone between the in vitro bench top 
models and the in vivo clinical studies.  
The successful development of this model could serve to decrease in vivo 
corneal wound healing studies in the horse, while providing an effective platform for 
equine corneal wound healing research. 
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ABSTRACT 
Purpose: To establish a physiologically relevant ex vivo equine corneal wound 
healing model.  
Methods: Fourteen globes were harvested from healthy horses within two hours of 
humane euthanasia for reasons unrelated to this study and immediately processed. 
Corneas were randomly assigned to one of the following groups: wounded (n=8) or 
unwounded (n=6) controls. In the wounded group, the axial cornea was ulcerated 
with a 6 mm filter paper disk soaked in 1 N sodium hydroxide (NaOH) at Time 0. 
Corneoscleral rims were excised 2 mm posterior to the limbus and corneal cups 
cultured in complete medium using an air-liquid interface model. The medium bathed 
the corneal cup eight times per minute to simulate normal horse blinking. Evaluation 
of corneal healing was performed daily and included fluorescein staining and a 
modified Hackett-McDonald ocular scoring system which included the calculated 
ulcer area. Corneas were randomly assigned to undergo further processing via 
histopathology at 24 hour (T24; n=5), 48 hours (T48; n=5), and 72 hours (T72; n=4) 
post wounding. Additionally, RNAscope in situ hybridization assay was performed 
according to the manufacturer’s instructions to evaluate IL-6 expression. 
Results: All wounded corneas healed within 72 hours. Histologically, normal corneal 
architecture was seen including intact epithelium, minimal stromal edema and the 
presence of endothelium. Interleukin-6 expression increased in wounded equine 
corneas compared to unwounded controls. The greatest IL-6 expression was in the 
basal epithelial layer, close to the wound margin. As the corneal wound healing 
progressed, IL-6 expression decreased. 
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Conclusions: The equine air-liquid interface, ex vivo, corneal wound healing model 
is an effective and physiologically relevant model. This model can be utilized to 
reduce or eliminate the use of live horses for corneal wound healing studies, while 
providing an effective platform for corneal wound healing research in this species. 
 
 
INTRODUCTION 
 
Corneal ulcers are very common in horses, and with a lack of appropriate 
treatment, they present an imminent risk for the eye and for vision.1 If not identified 
early or if secondary infection occurs, keratomalacia caused by various proteases 
acting on corneal collagen, may develop. This condition may lead to perforation of 
the eye.  However, despite the horse being predisposed to corneal injury (large eye 
size, lateral skull placement, exuberant behavior) and the frequency of ophthalmic 
presentations to the veterinarian,1 our knowledge base of equine corneal ulceration 
resolution is lacking.  
Corneal wound healing is a complex process that involves two basic steps – 
cellular migration to cover the wound followed by mitosis of the epithelial cells to fill 
in the defect.2,3 Physical damage to the cornea’s outer most layer, the epithelium, is 
the most common cause of wounding and it is associated with signs of ocular pain 
including blepharospasm and lacrimation. As the injured eye runs the risk of 
permanent, vision altering consequences or even perforation, it is not surprising that 
prompt and aggressive treatment is of paramount importance. Treatment of these 
corneal disorders can be time consuming, costly and frustrating for both the owner 
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and the patient, and should a superficial, uncomplicated erosion not be healed within 
72 hours, it should be considered complicated and is therefore in danger of 
perforation.1 In these cases, painful inflammation is likely involved, and clinical signs 
of reflex uveitis may be present and include photophobia, corneal edema and 
aqueous flare.  
 Despite the high prevalence of corneal disease and ulceration in the horse, 
the importance of a clear visual axis in this species, and the complexity of corneal 
wound healing, few in vivo studies are hypothesis driven. Instead, most studies are 
heavily devoted to retrospective studies, reviewing patients’ medical records.4-11 
Only a few prospective corneal wound healing studies have been conducted in vivo 
to date.12,13 The limitations of such studies include small sample size, high cost, 
ethical concerns, and large variation amongst few subjects that often results in a 
lack of statistical significance.14 
 In the laboratory setting, in vitro work possesses its own set of limitations 
including obtaining clinically relevant results.15-17 By experimenting on individual 
corneal cell types separately from neighboring layers, in vitro research may be an 
overly simplified model that lacks the dynamic, physiologic events of the in vivo 
model. In vitro pure cell culture lines are not able to simulate the cornea’s complex 
molecular processes nor the interactions and ‘cross talk’ amongst the corneal layers, 
especially the epithelium and stroma. For example, it is well-known that epithelial 
and stromal interactions are mediated by paracrine expression and that autocrine 
signaling is likely occurring as well.18,19 Therefore, the in vitro researcher may be 
faced with the obstacle of obtaining clinically applicable results.  
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 The inherent challenge comes in the desire to learn more about these 
involved processes without either harming healthy animals in vivo or struggling with 
clinical applicability and physiologic relevance in vitro. The ex vivo model has been 
developed in other species,20,21 and represents a logical stepping stone between the 
equine in vitro ocular bench top models and the in vivo clinical studies, all while 
providing physiologically-based, clinically applicable conclusions.17,22 While effective, 
species specific, reproducible models of corneal wound healing are of paramount 
importance, the development of an equine ex vivo model could serve to decease in 
vivo corneal wound healing studies in the horse, all while maintaining the clinical 
relevance of the results.  
 Interleukin-6 (IL-6) is a potent immunologic mediator and it is involved in 
acute phases of inflammation.23 It is considered a myokine, or a cytokine produced 
from muscle. Upon its release from myocytes, it serves a protective, anti-
inflammatory role within the musculature.24,25 However, it is also a proinflammatory 
cytokine and its secretion from T cells and macrophages leads to inflammation and 
tissue damage especially following burn trauma.24,25 Additionally, IL-6 has been 
shown to increase in septic conditions in both humans and horses26 and high levels 
of IL-6 are expressed in equine disease processes such as endometritis27 and 
pneumonia.28 Previous equine dermatologic studies have shown significant 
increases in IL- 6 mRNA levels following pathogen-associated molecular pattern 
(PAMP) exposure to gram negative bacteria29 and in an epidermal wound healing 
model.30 Equine neutrophils express significantly more IL-6 than other mediators.31 
Given this, it is likely that IL-6 is one of the more systemically important equine 
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cytokines and may play a large role in equine corneal wound healing as well. 
Although IL-6 expression has been demonstrated in rabbits,32,33 mice,34-36 and 
humans37 post corneal wounding, its expression during corneal wound healing in the 
horse has not been studied to date. 
Therefore, the purpose of this study was two-fold. First, to establish an ex 
vivo model of equine corneal wound healing.  And second, to investigate the 
physiologic relevance of this model by evaluating the rate of epithelial wound 
healing, anatomical structure, and IL-6 expression in wounded and unwounded 
corneas. This study is at the heart of improved animal welfare and represents a 
logical stepping stone between the in vitro bench top models and the in vivo clinical 
studies.  
 
MATERIALS AND METHODS 
 
Corneas 
 Corneas were obtained from horses that were euthanized at the Iowa State 
University College of Veterinary Medicine Lloyd Veterinary Medical Center for 
reasons unrelated to this study. Fourteen eyes from eight horses were included. The 
median age and weight of the donors was 19.25 years (range 8-30 years) and 370 
kilograms (range 160-540 kgs), respectively. Of these eight horses, three were 
geldings and five were mares and breeds represented included three Quarter 
Horses/Quarter Horses crosses, 3 ponies, one Paint and one Peruvian Paso.  All 
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horses were free of systemic and ocular disease. Two eyes (one right and one left) 
were excluded due to ophthalmic disease.  
 
Corneal wounding 
 Immediately following humane euthanasia, globes were enucleated, rinsed in 
2% betadine (Select Medical Products, Jacksonville, FL, USA), and placed in 1x 
phosphate buffered saline (PBS; Life Technologies, Grand Island, NY, USA). All 
further processing occurred within two hours of humane euthanasia. Globes were 
randomly assigned to wounded (n=8) or unwounded (n=6) control groups. If one of 
the eyes was excluded the fellow eye was assigned to the wounded group. 
Wounded corneas included 4 right eyes and 4 left eyes, while unwounded corneas 
included 3 right eyes and 3 left eyes. During all processing steps, a delicate task 
wiper (Kimwipes, Kimberly-Clark, Roswell, GA, USA) wet with 1X PBS was used to 
facilitate holding of the eyeball. For the eight wounded corneas, an alkali burn model 
was employed in which a 6 mm filter paper disc soaked in 1 N sodium hydroxide 
(NaOH) was applied to the axial cornea for 60 seconds (Fig. 3-1). After wounding, 
1X PBS was used to gently rinse the globe. Fluorescein stain (fluorescein sodium, 
Akron Inc., Lake Forest, IL, USA) was applied to confirm epithelial erosion and 
stromal exposure, and baseline ulceration measurements were obtained using a 
millimeter scale bar (Fig. 3-2). Wounding the cornea with the globe intact allowed for 
a crisp, well demarcated corneal ulceration. Once wounded, a #20 Bard Parker 
blade was used to score and then excise the sclera tangentially, approximately 2 
mm posterior to the limbus, freeing the corneoscleral (“corneal”) cup (Fig. 3-3). The 
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non-wounded globes were processed in a similar fashion, excluding the alkaline 
burn. 
 
Ex vivo cultures 
 Each corneal cup was placed in an individual 100 mm petri dish (Fischer 
Scientific, Waltham, MA, USA) along the dishes’ edge. Placement of the corneal cup 
along the side of dish minimized motion of the corneal cup while it was on the 
rocker. Additionally, great care was taken to ensure that the corneal cup retained its 
convex shape while introduced to the petri dish as no conformers were used. Once 
placed in the petri dish, approximately 25 mL of medium was added such that the 
medium came to the limbus but did not float the corneal cup off the floor of the petri 
dish. The medium consisted of Dulbecco’s modified Eagle’s medium and Ham’s F12 
medium (DMEM/HamF12 + GlutaMAX™, Gibco Life Technologies, Grand Island, 
NY, USA) in a 1:1 ratio. The medium was supplemented with 10% fetal bovine 
serum (Fischer Scientific, Waltham, MA, USA), 2.5µg/mL Amphotericin B (Life 
Technologies, Grand Island, NY, USA), 100 IU/mL penicillin (Life Technologies, 
Grand Island, NY, USA), 100 µg/mL streptomycin (Life Technologies, Grand Island, 
NY, USA), 10 ng/mL epidermal growth factor (Gibco Life Technologies, Frederick, 
MD, USA) and 5 µg/mL bovine pancreatic insulin. The petri dishes were placed on a 
rocker (Benchmark Scientific, Edison, NJ, USA) that was set at a 6 degree incline 
and 8 rocks per minute to actively bathe the corneal cup in medium in order to 
simulate blinking (Fig. 3-4). All corneas were incubated at 37 °C with 5% CO2 
humidity and monitored daily. Petri dishes and medium were changed out daily.  
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Corneal wound healing assessment  
 All daily evaluations for ulcer size were performed using slit-lamp 
biomicroscopy (Keeler SL4 PSL Classic, Keeler Instruments Inc., Windsor, UK) and 
a modified Hackett-McDonald ocular scoring system.38 Ulcer size was measured 
daily utilizing a millimeter scale, following application of fluorescein stain (Fig. 3-5, 3-
6), and the ulcer area was calculated  (𝐴 = 𝜋𝑟2) and averaged for each time point. 
Three and two corneas from the wounded and non-wounded group respectively, 
were submitted for RNAscope in situ hybridization and histopathology analysis 24 
(T24) and 48 (T48) hours post wounding, and two corneas from each group were 
submitted at 72 hours (T72) post wounding.  
 
Modified Hackett-McDonald Ocular Scoring System  
The modified Hackett-McDonald scoring system is used frequently in 
ophthalmology toxicology studies to describe ocular changes,38 and was employed 
in this study to describe corneal changes:  
a) Fluorescein intensity staining was graded 0-4 with 0=no fluorescein 
uptake; 0.5=no true uptake/epithelial erosion; 1=faint intensity stain; 2= 
mild intensity stain; 3= moderate intensity stain; 4= marked intensity stain. 
 
b) Ulcer location and description were noted.  
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c) Corneal edema was graded 0-4: 0=normal cornea with no edema; 1=slight 
loss of corneal transparency, all localized around the edge of ulceration; 
2=mild loss of corneal transparency, with edema extending outward from the 
edge of ulceration; 3=moderate loss of corneal transparency with further 
extension of edema from ulceration’s edge; 4=  complete loss of corneal 
transparency with marked edema diffusely. 
 
Histopathology 
 Corneal histopathology was performed on all corneas to assess structural 
integrity and pathologic changes to the corneal epithelium, stroma, Descemet’s 
membrane and endothelium. Each sample was fixed in 10% neutral buffered 
formalin (NBF) for 24 hours and then routinely stained with hematoxylin and eosin. 
All samples were evaluated using standard bright field microscopy.  
 
IL-6 RNAscope in situ hybridization  
RNA in situ hybridization (RNAscope, Hayward, CA, USA) was used in which 
single RNA IL-6 molecules within individual cells were visualized. All recommended 
RNAscope assay procedures were followed according to manufacturer’s instructions 
for formalin fixed paraffin embedded (FFPE) sections using RNAscope FFPE 
Reagent Kit 2.0 (Advanced Cell Diagnostics, Hayward, CA, USA). Once pulled from 
culture, corneas were placed in 10% NBF for 24 hours and then paraffin-embedded 
in preparation for IL-6 gene expression (RNAscope Target Probe C1, 16ZZ Ec-IL6, 
Advanced Cell Diagnostics, Hayward, CA, USA). The embedded tissue was then cut 
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into 5 µm sections, mounted on slides and allowed to air dry overnight at room 
temperature. The following morning, slides were baked for one hour at 60°C, 
deparaffinized using a xylene immersion twice for 15 minutes and then dehydrated 
in an ethanol series. Once dry, the slides underwent three pretreatment steps, for 30 
minutes each, to ensure access to corneal tissues. After the first pretreatment, the 
buffer was rinsed off the slides with deionized water and the slides were boiled at 
98-104°C for 30 minutes on a hot plate with pretreatment 2 buffer. The slides were 
again rinsed in deionized water and treated with pretreatment 3 buffer for 30 minutes 
at 40°C in the HybEZTM hybridization oven (Advanced Cell Diagnostics, Hayward, 
CA). This allowed for target probe access to the corneal tissue and blocking of 
endogenous peroxidase activity. The 16ZZ Ec-IL6 target probe was then applied to 
each 5 µm tissue section and the slides placed back in the HybEZTM hybridization 
oven for 2 hours at 40°C. After washing, a series of amplifiers was applied to each 
slide and they were then placed back in the oven. This included treatment with Amp 
1 solution for 30 minutes, Amp 2 solution for 15 minutes, Amp 3 solution for 30 
minutes and Amp 4 solution for 15 minutes. Each of these amplifying steps was 
baked at 40°C. Amp 5 and 6 solutions were applied for 30 and 15 minutes, 
respectively, at room temperature. After each of the six amplifying steps, slides were 
washed with wash buffer for two minutes at room temperature. In order to detect the 
RNA signal, the red reagent working solution was next applied to the tissue sections 
and incubated for 10 minutes at room temperature. Once rinsed with deionized 
water, the slides were counterstained with 50% hematoxylin, rinsed and dried. 
Positive and negative controls were run simultaneously to confirm the assay’s 
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validity and the corneal samples’ RNA quality and included a PPIB housekeeping 
gene for a positive assay control and a dabP bacterial gene for a negative control. 
The tissue sections were evaluated using standard bright field microscopy.  
 
RNAscope in situ hybridization evaluation criteria 
First, all slides from all time submissions were examined utilizing a standard 
bright field microscopy microscopeunder 4x, 10x, 20x, and 40x magnification for 
tissue and cell morphology and for 16ZZ Ec-IL6 target probe signal. The number of 
IL-6 mRNA transcripts was counted using ACD semi-quantitative scoring 
recommendation guidelines. Ten slides were randomly selected from each 
submission time point from each cornea and scored. These ten scored slides were 
used and those slides used to generate an average score for that particular corneal 
submission. All slides were scored at 400x. Scores were assigned 0-4 as described 
previously39 in which a 0 was noted if no staining was seen or <1 dot/10 cells was 
counted, a score of 1 was denoted if 1-3 dots/cell were seen, a 2 was noted if there 
were 4-9 dots/cell and few clusters were seen, a 3 was marked if 10-15 dots/cell 
were seen and <10% of those dots were in clusters, and a 4 was assigned if >15 
dots/cell were noted and >10% of dots were in clusters (Advanced Cell Diagnostics). 
All fields were scored by one investigator who was masked to the wounded or 
unwounded nature of the cornea and the time period of submission.  
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Microscopic imaging 
 Images were acquired using an Olympus BX53 standard bright field 
microscope (Olympus, Center Valley, PA, USA) and a DP73 microscope camera.  
 
 
RESULTS 
 
Corneal ulcer resolution  
 All wounded corneas healed within 72 hours and no unwounded corneas 
experienced any ulceration over the duration of this study. The area of re-
epithelialization (𝐴 = 𝜋𝑟2) via fluorescein stain was documented and averaged over 
time. The average corneal ulcer areas over time were T0=27.7±6.1, T24=18.6±6.3, 
T48=7.9±11.1 and T72=0 mm2 (Fig. 3-7).  
 
Modified Hackett-McDonald Ocular Scoring System 
 a) Fluorescein intensity (0-4) 
 All wounded corneas received maximum intensity stain scores at T0 which 
subsequently decreased until no stain uptake was seen at T72. Specific average 
intensity scores (±SD) included T0=3.9 ±0.2, T24=2.9±0.2, T48=1.6 ±1.0 and 
T72=0.   
 
 b) Fluorescein location and description 
 All ulcers were located on the axial cornea and were circular in shape.  
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 c) Corneal edema (0-4) 
 One wounded cornea experienced a slight loss of corneal transparency 
(score of 1) and paraxial corneal edema immediately adjacent to the ulceration was 
noted at T0. By T24 the edema had resolved and no other corneas experienced 
edema at any time point within  this study duration.   
 
Histopathology 
 All corneas displayed normal corneal architecture. Wounded corneas (Fig. 3-
8) showed a lack of epithelium but minimal stromal edema and intact endothelium. 
Unwounded corneas displayed epithelium of normal thickness, minimal stromal 
edema and adhered, intact endothelium (Fig. 3-9). The endothelium can be seen in 
both wounded (Fig. 3-10) and unwounded T72 submissions (Fig. 3-11).  
 
RNAscope in situ molecular detection analysis 
 The highest expression of IL-6 was seen in the basal epithelial cell layer adjacent 
to the wound bed in T24 wounded corneas, while the lowest IL-6 expression was 
seen nearest the limbus. By T72 all wounded corneas had healed and expressed 
minimal IL-6. Average RNAscope semi-quantitative scoring for each time submission 
group was calculated and included wounded RNAscope semi-quantitative scoring 
for each time point, including wounded T24=1.7 ±0.7, T48=0.9 ± 0.7, T72= 0.2± 0.4 
and unwounded T24=0.3 ± 0.5, T48=0 and T72=0 groups (Figs. 3-12- 3-14). 
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Decreased IL-6 expression was seen in the wounded corneas nearest the limbus 
(Fig. 3-15). Minimal diffuse IL-6 expression was seen in T24 unwounded corneas 
while T48 and T72 unwounded corneas expressed no IL-6 mRNA transcripts (Fig. 3-
16). 
 
DISCUSSION 
 
Ex vivo corneal wound healing models are becoming popular in recent years, 
as they maintain the dynamic, complex, physiological events of the in vivo model, 
while decreasing the need for live animals for this type of studies.20,40,41 In this study, 
we established an ex vivo model of equine corneal wound healing, and 
demonstrated its physiological relevance. The anatomical integrity of the different 
corneal layers was maintained throughout the study period. Apart from the ulcerated 
site, all corneas maintained a normal epithelial cell layer, and exhibited a minimal 
amount of stromal edema (Fig. 3-10).  In addition, a healthy endothelial cell layer 
and Descemet’s membrane were noted in all corneas in our study (Fig. 3-10). It is 
noteworthy that in other ex vivo corneal wound healing models,40 as well as in our 
previous experience (not published), the endothelium is usually damaged or missing 
where it was contacted by the conformer. Some studies do not mention the integrity 
of their endothelial layer.21 Due to the unique anatomical features of the equine 
cornea (i.e. greater diameter and thickness), a conformer was not needed in our 
model, leading to a healthy, intact endothelium. As a result, minimal corneal stromal 
edema was present, compared to models utilizing conformers.21,40-42  
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All corneal ulcers in our study healed within 72 hours from wounding, 
consistent with previous publications.1 Corneal epithelial wounds heal by cellular 
migration and proliferation. Although the mechanism of corneal wound healing is not 
fully understood, studies have demonstrated the importance of IL-6 in this complex 
process.33 Interleukin-6 is upregulated following corneal injury in humans, as well as 
in animal and in vitro models.34,36,37,43 The increase in IL-6 expression facilitates, and 
expedites, epithelial wound closure.36,44,45 Fibronectin has been shown to induce 
corneal epithelial cells migration, a process that is enhanced by IL-6 in vivo.46 In 
addition, IL-6 reduces the production of matrix metalloproteinase-2, which may have 
deleterious effect on wounded cornea.47 Furthermore, the suppression of IL-6 
expression has negative effect on corneal epithelial cell migration, both in vitro and 
in vivo.43  
The results of our study demonstrate increased IL-6 expression in injured 
corneas, in agreement with other studies. Peak IL-6 expression has seen reported at 
one day, or 24 hours post corneal surgery in human patients,37 and 7 days after 
corneal alkali burn in mice34 and rabbits.33 The peak IL-6 expression in our study 
was noted 24 hours after corneal wounding, similar to the finding of Resan et al.37 
However, since in our study the first time point for IL-6 expression was 24 hours post 
injury, we cannot rule out an earlier peak of IL-6 expression. While we and 
others33,34 used an alkali burn model, we used equine corneas, while Sotozono et al 
used mouse corneas34 and Imanishi et al used rabbit corneas.33 The interspecies 
differences may account for the discrepancy in IL-6 peak expression time in these 
studies.  
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The RNAscope in situ hybridization technique was used in our study. This 
technique is a robust, highly specific and highly sensitive method for analyzing RNA 
biomarkers, and allows for molecular visualization of gene expression all while 
maintaining tissue integrity.48 Utilizing this modality, we showed that IL-6 expression 
was the greatest adjacent to the wound bed, in the basal epithelial cell layer, similar 
to the findings of others.34 Interestingly, Sumioka at al found that transient receptor 
potential cation channel subfamily V member 1 (TRPV1) is present mainly in the 
basal layer of mouse and rat corneal epithelium, and that TRPV1 is required for the 
upregulation of IL-6.43  
This study presents a novel ex vivo equine corneal wound healing model. In 
this model, corneal architecture (including corneal endothelium) was maintained, 
unlike other ex vivo corneal wound healing models. Hence, this model better mimics 
in vivo events as seen by timely wound healing and IL-6 upregulation. In conclusion, 
this novel ex vivo corneal wound healing model is physiologically relevant, and may 
be utilized for future studies of corneal wound healing, while decreasing or negating 
the use of live, healthy animals for such studies. 
 
CONCLUSIONS 
 
 In summation, this study established an air-liquid interface with medium 
bathing ex vivo model of equine corneal wound healing. Ulcer resolution was noted 
to be consistent and timely, mimicking the in vivo response of an uncomplicated, 
superficial ulceration that heals within 72 hours. Histologically, intact epithelium, 
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minimal stromal edema and presence of the endothelium were seen. Further, IL-6 
analysis via RNAscope quantification displayed an upregulated response of this pro-
inflammatory cytokine in wounded corneas versus unwounded controls. This finding 
parallels a previous in vivo rabbit study which demonstrated that the metabolically 
active basal epithelial layer expressed the greatest amount of IL-6.33 The expression 
and elucidation of this important cytokine, coupled with the timely macroscopic 
ulceration resolution and the maintenance of corneal architecture histologically, 
validates the physiologic relevance of this model.   
Therefore, this model can be utilized to reduce or eliminate the use of live horses for 
corneal wound healing studies, while providing an effective platform for corneal 
wound healing research in this species. 
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Figures for Chapter 3 
 
 
Figure 3-1: Equine globe showing application of the 6 mm filter paper disk soaked in 
NaOH applied to the axial cornea. 
 
 
 
Figure 3-2: Freshly wounded cornea showing circular area of ulceration that is 
fluorescein positive. 
 
 
 
 
Figure 3-3: Corneoscleral cup excision employing a Bard Parker blade placed 
approximately 2 mm posterior to the limbus. The anterior portion that contains the 
cornea (ie “corneal cup”) will then be placed in the incubator cornea side up.  
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Figure 3-4: Rocker setup including petri dishes with corneas. Note the 6 degree 
incline that aided in bathing the corneas eight times per minute. The rocker was 
placed in the CO2 incubator.  
 
 
 
Figure 3-5. Representative wounded cornea at T24. Note the axial, circular 
fluorescein uptake highlighted by cobalt blue light and the millimeter scale bar.  
 
 
 
Figure 3-6: Representative wounded cornea at T48. Note the pinpoint axial 
fluorescein uptake highlighted by cobalt blue light versus the much larger fluorescein 
positive area shown in the above T24 figure 3-5. 
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Figure 3-7: Values for the average ulcer area over time including T0=27.7±6.1, 
T24=18.6±6.3, T48=7.9±11.1 and T72=0 mm2. 
 
 
 
 
Figure 3-8. Histopathology of representative T48 wounded cornea stained with 
hematoxylin and eosin. Note the lack of epithelium (black arrow) superficially and the 
occasional keratocyte (blue arrow) in the stroma. 400x. 
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Figure 3-9: Histopathology of representative T48 unwounded cornea stained with 
hematoxylin and eosin. Note the robust 16 cell layer thick epithelium with the basal 
cell layer (*), wing cell layer (**) and superficial epithelial layer (***). Additionally, 
note the lack of edema within the stromal layer. 400x. 
 
 
 
Figure 3-10: Representative wounded corneal submission at T72 displaying intact 
endothelium in a nonwounded zone. Note the robust epithelial layer, the minimal 
stromal edema, the thickened Descemet’s membrane (abbreviated DM) and the 
intact endothelial layer (thick blue arrow). 100x.  
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Figure 3-11. Representative unwounded corneal submission at T72 displaying intact 
endothelium. Note the robust superficial epithelial layer, the minimal stromal edema, 
the thickened Descemet’s membrane, and the intact endothelial layer (black arrow). 
40x.  
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Figure 3-12: RNAscope semi-quantitative scoring for each time point including 
wounded T24=1.7 ±0.7, T48=0.9 ± 0.7, T72= 0.2± 0.4 and unwounded T24=0.3 ± 
0.5, T48=0 and T72=0 groups.   
 
  
Figure 3-13: RNAscope in situ hybridization analysis of a representative T24 
wounded cornea immediately adjacent to the alkaline burn. Note the increased IL-6 
expression in the basal epithelial cell layer (*). 400x. 
 
 
 
  
Figure 3-14: RNAscope in situ hybridization analysis of paraxial corneal section of a 
representative T24 wounded cornea. Note the increased IL-6 expression in the basal 
epithelial cell layer (*) but that the number of IL6 mRNA transcripts are fewer than 
the above Figure 3-13 as this image is closer to the limbus. 400x. 
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Figure 3-15: RNAscope in situ hybridization analysis of a representative, perilimbal 
area of T24 wounded cornea. Note the lack of IL-6 expression in the basal epithelial 
layer (*) as this is the farthest point from the wound. 400x.  
 
 
 
  
Figure 3-16: RNAscope in situ hybridization analysis of a representative, axial area 
of T72  unwounded cornea. No IL-6 expression is seen in the basal epithelial layer 
(*). 400x. 
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CHAPTER 4. GENERAL CONCLUSIONS 
 
 
Summary  
 
Corneal disease is one of the most significant causes of impaired vision in the 
horse world-wide. This is likely due to several factors including a prominent globe, 
the lateral location of the globe within the skull and the equines’ exuberant and head 
throwing behavior. As such, the horse is predisposed to corneal injury. Although 
equine corneal disease and the subsequent wound healing cascade is a complex 
process whose mechanisms are still not fully understood, it is well known that 
inflammatory cells and their secretory products such as cytokines and growth factors 
are involved. However, despite the high prevalence of corneal disease and 
ulceration in the horse, the importance of a clear visual axis in this species, and the 
complexity of corneal wound healing, research is limited and more heavily devoted 
to in vivo studies. Limitations of these in vivo studies include ethical concerns, cost, 
small sample sizes, and large variation amongst subjects. In vitro research may be 
an overly simplified model that lacks the dynamic, physiologic events of the in vivo 
model as these cell culture lines are not able to replicate ‘cross talk’ across corneal 
layers. This novel ex vivo model bridges the gap between in vivo and in vitro 
research and displayed physiologic relevance via timely ulcer resolution, 
histologically intact corneal layers and IL-6 expression in wounded versus 
unwounded controls. As such, this model can be utilized to reduce or eliminate the 
use of live horses for corneal wound healing studies, while providing an effective 
platform for corneal wound healing research in this species, including, but not limited 
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to, investigation of corneal wound healing physiology, and evaluation of different 
treatment modalities.  
 
 
Concluding Remarks 
 
 The ex vivo equine corneal wound healing model that was described is not 
only a novel model but one that has shown physiologic relevance when comparing 
results to in vivo ulcer resolution healing times, maintenance of anatomic structure 
as seen histologically, and IL-6 expression that mimics previous in vivo studies. 
Hence, this model can be utilized in order to improve our knowledge of equine 
corneal wound healing while reducing the use of live horses for corneal wound 
healing studies.  
